L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells (Q42794875)

7 November 2017

L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells (English)

1 reference

7 November 2017

1 reference

6

Holger Moch

1 reference

7 November 2017

Kai Doberstein

1

1 reference

7 November 2017

Anja Wieland

2

1 reference

7 November 2017

Sophia B Boyoung Lee

3

1 reference

7 November 2017

Roman A Alexander Blaheta

4

1 reference

7 November 2017

Steffen Wedel

5

1 reference

7 November 2017

Peter Schraml

7

1 reference

7 November 2017

Josef Pfeilschifter

8

1 reference

7 November 2017

Glen Kristiansen

9

1 reference

7 November 2017

Paul Gutwein

10

1 reference

7 November 2017

language of work or name

English

0 references

publication date

19 November 2010

1 reference

7 November 2017

1 reference

7 November 2017

32

1 reference

7 November 2017

3

1 reference

7 November 2017

262-270

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

7 November 2017

1 reference

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

The L1 cell adhesion molecule as a target for radioimmunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Nephric lineage specification by Pax2 and Pax8

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

A PANorama of PAX genes in cancer and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

A binding site for homeodomain and Pax proteins is necessary for L1 cell adhesion molecule gene expression by Pax-6 and bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Anti-neuroblastoma antibody chCE7 binds to an isoform of L1-CAM present in renal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Tumour suppression by the human von Hippel-Lindau gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

The cellular basis of kidney development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ249

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGQ249

1 reference

7 November 2017

1 reference